Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53

United States Fiscal year ends December CIK 0001867096 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$1.21M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$7.61M

$4.48M on a plan · $711.33K straight out of an exercise

Sold at will

$2.41M

5 of 42 sales

Net

−$6.40M

−$1.21M against sales at will